+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Urokinase receptor ligands



Urokinase receptor ligands



Official Gazette of the United States Patent & Trademark Office Patents 1210(1): 494




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144190

Download citation: RISBibTeXText


Related references

Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. Journal of Biological Chemistry 269(41): 25668-25676, 1994

Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic a2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. The Journal of Biological Chemistry 269: 668-76, 1994

Peptide ligands of the urokinase receptor. Official Gazette of the United States Patent & Trademark Office Patents 1286(3), 2004

The discovery of novel urokinase receptor ligands by bacteriophage display and combinatorial chemistry. Fibrinolysis 10(Suppl. 3): 21, 1996

Random peptide bacteriophage display as a probe for urokinase receptor ligands. Biological Chemistry 383(1): 149-158, 2002

Cyclic peptide ligands that target urokinase plasminogen activator receptor. Official Gazette of the United States Patent & Trademark Office Patents 1249(3), 2001

Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein. Journal of the American Society of Nephrology 15(8): 2090-2102, 2004

Purified a2-macroglobulin receptor/LDL receptor-related protein binds urokinase plasminogen activator inhibitor type-1 complex. Evidence that the a2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. The Journal of Biological Chemistry 267: 543-6, 1992

High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: Effects on tumor growth and spread. FEBS Letters 528(1-3): 212-216, 25 September, 2002

Design and biological activity of new high-affinity ligands for the urokinase-type plasminogen activator receptor. Fields, Gregg B [Author], Tam, James P [Author], Barany, George [Author] Peptides for the new millennium 543-545, 2000

Invasion by esophageal cancer cells: Functional contribution of the urokinase plasminogen activation system, and inhibition by antisense oligonucleotides to urokinase or urokinase receptor. Clinical & Experimental Metastasis 17(1): 77-85, 1999

A hybrid protein of urokinase growth-factor domain and plasminogen-activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor. European Journal of Biochemistry 207(1): 177-183, 1992